Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation
Open Access

Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model

Amal Saidi, Tania A. Stallons, Amy G. Wong and Julien J. Torgue
Journal of Nuclear Medicine November 2024, 65 (11) 1769-1775; DOI: https://doi.org/10.2967/jnumed.124.268101
Amal Saidi
1Orano Med SAS, Paris, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tania A. Stallons
2Orano Med LLC, Plano, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy G. Wong
2Orano Med LLC, Plano, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien J. Torgue
2Orano Med LLC, Plano, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 11 1769-1775
DOI 
https://doi.org/10.2967/jnumed.124.268101
PubMed 
39327021

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 30, 2024
  • Accepted for publication September 4, 2024
  • Published online November 1, 2024.

Article Versions

  • previous version (September 26, 2024 - 12:46).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.

Author Information

  1. Amal Saidi1,
  2. Tania A. Stallons2,
  3. Amy G. Wong2 and
  4. Julien J. Torgue2
  1. 1Orano Med SAS, Paris, France; and
  2. 2Orano Med LLC, Plano, Texas
  1. For correspondence or reprints, contact Amal Saidi (amal.saidi{at}oranomed.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
    Clément Morgat, Heying Duan, Simone Dalm, Elif Hindié, Thomas Günther, Bernd J. Krause, Vasko Kramer, Florine Cavelier, Andrew W. Stephens, Stephen Moran, Laura Lamb, Andrei Iagaru
    Journal of Nuclear Medicine 2025

Article usage

Article usage: September 2024 to April 2025

AbstractFullPdf
Sep 2024137158114
Oct 2024315463124
Nov 2024460742139
Dec 202415436399
Jan 202510528989
Feb 20256229161
Mar 20255923768
Apr 20254625057
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (11)
Journal of Nuclear Medicine
Vol. 65, Issue 11
November 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model
Amal Saidi, Tania A. Stallons, Amy G. Wong, Julien J. Torgue
Journal of Nuclear Medicine Nov 2024, 65 (11) 1769-1775; DOI: 10.2967/jnumed.124.268101

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model
Amal Saidi, Tania A. Stallons, Amy G. Wong, Julien J. Torgue
Journal of Nuclear Medicine Nov 2024, 65 (11) 1769-1775; DOI: 10.2967/jnumed.124.268101
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
  • Google Scholar

More in this TOC Section

  • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
  • 161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas
  • 212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
Show more Basic Science Investigation

Similar Articles

Keywords

  • [212Pb]Pb-DOTAM-GRPR1
  • cancer
  • peptide
  • targeted α-therapy
SNMMI

© 2025 SNMMI

Powered by HighWire